Financhill
Back

Marinus Pharmaceuticals Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Sell
31

MRNS
Marinus Pharmaceuticals

Last Price:
0.34
Seasonality Move:
12.73%

7 Day Trial

ALL ACCESS PASS

$ 7

Yours Free! Top SIX AI Dividend Stocks Right Now

NO CREDIT CARD REQUIRED!

Marinus Pharmaceuticals Price Quote

$0.34
+0.00 (+3.69%)
(Updated: November 5, 2024 at 3:31 AM ET)

Marinus Pharmaceuticals Key Stats

Sell
31
Marinus Pharmaceuticals (MRNS) is a Sell

Day range:
$0.31 - $0.34
52-week range:
$0.26 - $11.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.62
P/B ratio:
0%

Volume:
2M
Avg. volume:
4.4M
1-year change:
-95.2%
Market cap:
$18.5M
Revenue:
$31M
EPS:
$-2.66

How Much Does Marinus Pharmaceuticals Make?

Is Marinus Pharmaceuticals Growing As A Company?

Marinus Pharmaceuticals Stock Price Performance

What Is Marinus Pharmaceuticals 52-Week High & Low?

Marinus Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Marinus Pharmaceuticals?

Is Marinus Pharmaceuticals Cash Flow Positive?

  • What Is MRNS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$120.5M
  • What Is Marinus Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $9.1M
  • What Is Marinus Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $48.2M

Marinus Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    MRNS return on invested capital is -180.94%
  • What Is Marinus Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -93.58%
  • What Is MRNS Return On Equity?
    ROE is a measure of profitability and is -1150.43%

Marinus Pharmaceuticals Earnings Date & Stock Price

Marinus Pharmaceuticals Competitors

Marinus Pharmaceuticals Dividend Yield

Marinus Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -8.86%
Revenue: 32.48% -15.26%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 2.38
Upside from Last Price: 608.74%

Major Shareholders

  • How many MRNS shares are owned by institutional investors?
    66.4M MRNS shares are owned by institutional investors
  • How many MRNS shares are owned by insiders?
    1M MRNS shares are owned by insiders